tiprankstipranks
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
India Market
AARTIDRUGS
Aarti Drugs Limited
RESEARCH TOOLSreports
Want to see IN:AARTIDRUGS full AI Analyst Report?

Aarti Drugs Limited (AARTIDRUGS) Ratios

3 Followers

Aarti Drugs Limited Ratios

IN:AARTIDRUGS's free cash flow for Q2 2026 was ₹0.37. For the 2026 fiscal year, IN:AARTIDRUGS's free cash flow was decreased by ₹ and operating cash flow was ₹0.10. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.59 1.60 1.66 1.57 1.48
Quick Ratio
 1.06 1.03 1.05 1.03 0.92
Cash Ratio
 <0.01 <0.01 <0.01 <0.01 0.02
Solvency Ratio
 0.21 0.19 0.19 0.18 0.22
Operating Cash Flow Ratio
 0.17 0.29 0.45 0.14 0.07
Short-Term Operating Cash Flow Coverage
 0.48 0.75 1.25 0.33 0.17
Net Current Asset Value
₹ 2.02B₹ 1.33B₹ 1.70B₹ 2.64B₹ 2.22B
Leverage Ratios
Debt-to-Assets Ratio
 0.20 0.24 0.23 0.25 0.25
Debt-to-Equity Ratio
 0.37 0.45 0.44 0.51 0.52
Debt-to-Capital Ratio
 0.27 0.31 0.31 0.34 0.34
Long-Term Debt-to-Capital Ratio
 0.14 0.17 0.18 0.15 0.12
Financial Leverage Ratio
 1.82 1.88 1.90 2.03 2.13
Debt Service Coverage Ratio
 0.84 0.67 0.80 0.58 0.66
Interest Coverage Ratio
 7.19 20.43 7.09 7.13 12.06
Debt to Market Cap
 0.17 0.19 0.13 0.19 0.14
Interest Debt Per Share
 66.91 71.03 65.20 69.77 61.20
Net Debt to EBITDA
 1.83 2.12 1.72 1.93 1.51
Profitability Margins
Gross Profit Margin
32.94%35.40%33.65%13.59%15.62%
EBIT Margin
9.51%9.69%10.81%9.62%11.81%
EBITDA Margin
12.12%12.03%12.85%11.47%13.82%
Operating Profit Margin
9.44%30.70%10.62%9.75%11.59%
Pretax Profit Margin
8.22%8.87%9.31%8.25%10.85%
Net Profit Margin
7.60%7.04%6.78%6.12%8.24%
Continuous Operations Profit Margin
7.60%7.04%6.79%6.12%8.24%
Net Income Per EBT
92.43%79.40%72.78%74.19%75.95%
EBT Per EBIT
87.06%28.90%87.67%84.65%93.61%
Return on Assets (ROA)
6.92%6.53%7.05%6.87%9.29%
Return on Equity (ROE)
13.55%12.28%13.38%13.95%19.78%
Return on Capital Employed (ROCE)
12.80%42.17%16.41%17.99%22.75%
Return on Invested Capital (ROIC)
10.12%28.14%10.17%10.48%13.11%
Return on Tangible Assets
6.96%6.55%7.16%6.87%9.29%
Earnings Yield
5.62%5.35%4.06%5.32%5.16%
Efficiency Ratios
Receivables Turnover
 3.09 3.17 3.59 3.12 3.21
Payables Turnover
 3.60 3.71 3.73 3.83 4.48
Inventory Turnover
 3.50 3.26 3.45 3.66 3.99
Fixed Asset Turnover
 2.00 2.01 2.40 3.07 3.25
Asset Turnover
 0.91 0.93 1.04 1.12 1.13
Working Capital Turnover Ratio
 4.77 4.65 4.73 5.45 5.44
Cash Conversion Cycle
 120.91 128.42 109.60 121.70 123.57
Days of Sales Outstanding
 118.18 114.98 101.70 117.11 113.62
Days of Inventory Outstanding
 104.14 111.94 105.71 99.79 91.41
Days of Payables Outstanding
 101.40 98.50 97.82 95.19 81.46
Operating Cycle
 222.31 226.92 207.41 216.89 205.03
Cash Flow Ratios
Operating Cash Flow Per Share
 16.70 26.69 38.86 14.49 7.52
Free Cash Flow Per Share
 6.36 7.36 14.36 -3.29 -8.89
CapEx Per Share
 10.34 19.33 24.51 17.78 16.41
Free Cash Flow to Operating Cash Flow
 0.38 0.28 0.37 -0.23 -1.18
Dividend Paid and CapEx Coverage Ratio
 1.62 1.31 1.52 0.77 0.43
Capital Expenditure Coverage Ratio
 1.62 1.38 1.59 0.81 0.46
Operating Cash Flow Coverage Ratio
 0.26 0.40 0.64 0.22 0.13
Operating Cash Flow to Sales Ratio
 0.06 0.10 0.14 0.05 0.03
Free Cash Flow Yield
1.67%2.14%3.14%-0.97%-2.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.80 18.70 24.64 18.81 19.38
Price-to-Sales (P/S) Ratio
 1.35 1.32 1.67 1.15 1.60
Price-to-Book (P/B) Ratio
 2.24 2.30 3.30 2.62 3.83
Price-to-Free Cash Flow (P/FCF) Ratio
 59.81 46.64 31.86 -102.64 -48.26
Price-to-Operating Cash Flow Ratio
 22.78 12.86 11.77 23.31 57.06
Price-to-Earnings Growth (PEG) Ratio
 1.11 -16.53 7.38 -1.00 -0.73
Price-to-Fair Value
 2.24 2.30 3.30 2.62 3.83
Enterprise Value Multiple
 13.00 13.07 14.72 11.96 13.07
Enterprise Value
 40.40B 37.52B 47.82B 37.28B 44.94B
EV to EBITDA
 13.00 13.07 14.72 11.96 13.07
EV to Sales
 1.57 1.57 1.89 1.37 1.81
EV to Free Cash Flow
 69.59 55.65 36.07 -122.33 -54.58
EV to Operating Cash Flow
 26.51 15.34 13.32 27.78 64.54
Tangible Book Value Per Share
 169.83 148.65 134.81 128.71 111.90
Shareholders’ Equity Per Share
 169.79 149.39 138.76 128.77 111.92
Tax and Other Ratios
Effective Tax Rate
 0.08 0.21 0.27 0.26 0.24
Revenue Per Share
 281.21 260.48 273.77 293.31 268.75
Net Income Per Share
 21.37 18.35 18.56 17.96 22.14
Tax Burden
 0.92 0.79 0.73 0.74 0.76
Interest Burden
 0.86 0.92 0.86 0.86 0.92
Research & Development to Revenue
 0.00 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.06 0.05 0.04 0.03 0.03
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.60 1.45 2.09 0.60 0.26
Currency in INR